Previous Article | Next Article 
Infection and Immunity, October 2001, p. 5991-5996, Vol. 69, No. 10
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.10.5991-5996.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Impaired Pulmonary NF-
B Activation in Response
to Lipopolysaccharide in NADPH Oxidase-Deficient Mice
M. Audrey
Koay,1
John W.
Christman,1,2,*
Brahm H.
Segal,3
Annapurna
Venkatakrishnan,1
Thomas R.
Blackwell,2
Steven M.
Holland,3 and
Timothy S.
Blackwell1,2
Department of Medicine, Division of Allergy,
Pulmonary, and Critical Care Medicine, Vanderbilt University School of
Medicine, Nashville, Tennessee 272321;
Department of Veterans Affairs, Nashville, Tennessee
372432; and Laboratory of Host Defenses,
National Institutes of Health, Bethesda, Maryland
208923
Received 19 March 2001/Returned for modification 24 May
2001/Accepted 12 July 2001
 |
ABSTRACT |
Reactive oxygen species (ROS) are thought to be involved in
intracellular signaling, including activation of the transcription factor NF-
B. We investigated the role of NADPH oxidase in the NF-
B activation pathway by utilizing knockout mice
(p47phox
/
) lacking the p47phox component of
NADPH oxidase. Wild-type (WT) controls and p47phox
/
mice were treated with intraperitoneal (i.p.) Escherichia
coli lipopolysaccharide (LPS) (5 or 20 µg/g of body weight).
LPS-induced NF-
B binding activity and accumulation of RelA in
nuclear protein extracts of lung tissue were markedly increased in WT
compared to p47phox
/
mice 90 min after treatment with
20 but not 5 µg of i.p. LPS per g. In another model of lung
inflammation, RelA nuclear translocation was reduced in
p47phox
/
mice compared to WT mice following treatment
with aerosolized LPS. In contrast to NF-
B activation in
p47phox
/
mice, LPS-induced production of macrophage
inflammatory protein 2 in the lungs and neutrophilic lung inflammation
were not diminished in these mice compared to WT mice. We conclude that
LPS-induced NF-
B activation is deficient in the lungs of
p47phox
/
mice compared to WT mice, but this abnormality
does not result in overt alteration in the acute inflammatory response.
 |
INTRODUCTION |
Proinflammatory stimuli such as
endotoxin (lipopolysaccharide [LPS]), tumor necrosis factor
(TNF-
), and interleukin 1
(IL-1
) are potent triggers for the
NF-
B activation pathway (2, 23). The same stimuli also
elicit an oxidative cellular stress response (6, 8, 30). A
role for reactive oxygen species (ROS) as mediators of cellular events
or as secondary messengers has been proposed (22), but
little supportive whole-animal data exist. A number of potential
mechanisms could account for the intracellular effects of ROS,
including modulation of calcium flux and protein phosphorylation
(29) or alterations in protein conformation and function
(17), but the exact pathway remains to be defined.
NF-
B regulates gene expression of many proinflammatory mediators,
including cytokines (TNF-
and IL-6), CXC chemokines (IL-8; gro
,
, and
; macrophage inflammatory protein-2 [MIP-2]; and keratinocyte-derived cytokine [KC]) and enzymes (inducible
nitric oxide synthase and COX) (3). Gene expression of
these molecules is related to and may be the cause of acute
neutrophilic inflammation and the systemic inflammatory response
syndrome (23). Heterodimeric NF-
B is retained in the
cytoplasm by binding to members of the inhibitory (I
B) family. The
key step in NF-
B activation is the inducible phosphorylation of
N-terminal serines (Ser 32 and 36) of I
B-
. Phosphorylation
targets I
B-
for ubiquitination of N-terminal lysine residues,
which marks I
B-
for 28S proteasome degradation, allowing nuclear
translocation and DNA binding by the free NF-
B heterodimer
(10). The DNA binding avidity of NF-
B can be modulated
by changes in the cellular redox state (12).
NADPH oxidase is the main cellular source of ROS in mononuclear and
granulocytic leukocytes (1). The key role of NADPH oxidase
in host defense is illustrated by the immune deficiency syndrome
chronic granulomatous disease, which is an autosomal or X-linked
deficiency in NADPH oxidase that causes recurrent life-threatening
infections and tissue granuloma formation (28). Mouse
knockout models of X-linked (24) and autosomal
(p47phox) defects in the NADPH oxidase system
have been developed (18). We examined the effect of
treatment with intraperitoneal (i.p.) and aerosolized LPS on activation
of NF-
B in p47phox knockout mice
(p47phox
/
) with defective NADPH oxidase
function compared to that in C57/B6 wild-type (WT) control mice.
Following treatment with LPS, p47phox
/
mice
exhibited reduced nuclear NF-
B binding activity in lung tissue and
reduced immunoreactive RelA in nuclear protein extracts. These
alterations in the NF-
B activation pathway, however, were not
associated with alterations in the development of neutrophilic alveolitis or MIP-2 production in response to treatment with either i.p. or aerosolized LPS.
 |
MATERIALS AND METHODS |
Materials.
Escherichia coli LPS (serotype 055:B5)
was obtained from Sigma (St. Louis, Mo.). The double-stranded consensus
NF-
B motif 5'-GATCGAGGGGA-CTTTCCCTAAAAGC-3', used in
electrophoretic mobility shift assays (EMSA), was obtained from
Stratagene (La Jolla, Calif.). [
-32P]ATP was
obtained from NEN-Dupont (Boston, Mass.), and T4 kinase and T4 kinase
buffer used for oligonucleotide labeling were obtained from New England
Biolabs (Beverly, Mass.). Antibodies to RelA (also called p65) and p50
used in performing EMSA supershifts and Western blots were obtained
from Santa Cruz Biotechnology (Santa Cruz, Calif.). Double-stranded
oligonucleotide Oct-1 was used as a nonspecific probe in the EMSA and
was obtained from Promega (Madison, Wis.). Enzyme-linked immunosorbent
assay (ELISA) kits used for cytokine measurements were purchased from
R&D, Minneapolis, Minn.
Animal model.
Homozygous p47phox
/
mice and littermate controls were generated as described previously
(18). These mice have been backcrossed 10 generations into
the C57/B6 strain and are derived from a single lineage. Mice were
housed in filtered air cages. They were fed standard, autoclavable chow
pellet diet and had free access to sterile water. Adult mice (between 6 and 10 weeks of age) weighing between 20 and 30 g were used for
all experiments.
Lyophilized Esherichia coli LPS was suspended in sterile
saline and administered to adult mice as a single i.p. injection at
doses of 5 or 20 µg/g of body weight. Animals were sacrificed 90 min
after i.p. injections. In other experiments, mice were exposed to
aerosolized LPS by placing them within a sealed container. LPS was
suspended in sterile saline and delivered as a continuous aerosol with
a driving flow rate of 8 liters/min by using a small-volume nebulizer
(Resigard II; Marquest Medical, Englewood, Colo.). The concentration of
aerosolized LPS used was 0.1 mg/ml, and all aerosol treatments were
given over a standardized 30-min interval. Following treatment, mice
were returned to sterile cages and were sacrificed 4 h later.
Mice were euthanized by carbon dioxide inhalation as recommended by the
Panel on Euthanasia of the American Veterinary Medical
Association.
Lung lavage fluid and tissue samples were collected
after death. Mouse
tracheas were cannulated with a 20-gauge blunt-tip
needle attached to a
1-ml syringe, and the lungs were lavaged
with sterile pyrogen-free
physiological saline until a total lavage
volume of 3 ml was collected.
Lungs were harvested by surgical
resection, and tissues were flash
frozen in liquid nitrogen and
stored at

70°C.
Quantification of neutrophilic lung infiltration.
Neutrophilic lung inflammation was measured as total and differential
cell counts in the lung lavage fluid. Total cell counts were determined
by using a grid hemocytometer. Differential cell counts were obtained
by staining a cytocentrifuge slide preparation with a modified
Wright's stain (Diff-Quik; Baxter, Miami, Fla.) and counting 300 to
400 cells in a cross-section.
Extraction of nuclear proteins from tissue samples.
Tissue
nuclear proteins were extracted from whole-lung tissue by the method of
Deryckere and Gannon (13). Briefly, 50 to 100 mg of tissue
was mechanically homogenized in liquid nitrogen, to which 4 ml of
buffer A (150 mM NaCl, 10 mM HEPES [pH 7.9], 0.6% [vol/vol] NP-40,
0.2 M EDTA, 0.1 M phenylmethylsulfonyl fluoride) was added. The
homogenate was transferred to a 15-ml Falcon tube and centrifuged at
850 × g in a tabletop centrifuge for 30 s to remove cellular debris. The supernatant was then transferred to a 50-ml
Falcon tube and incubated on ice for 5 min prior to being centrifuged
for 10 min at 3,500 × g. Supernatant was collected as
a cytoplasmic extract. The pellet was resuspended in 300 µl of buffer
B (sterile water, 25% [vol/vol] glycerol, 20 mM HEPES [pH 7.9], 5 M NaCl, 1 M MgCl2, 0.2 M EDTA,0.1 M
phenylmethylsulfonyl fluoride, 1 M dithiothreitol, 10 mg of benzamidine
per ml, 1 mg of pepstatin per ml, 1 mg of leupeptin per ml, 1 mg of
aprotinin per ml) and incubated on ice for 30 min. Following
centrifugation at 14,000 rpm in an Eppendorf microcentrifuge for 2 min,
the supernatant was collected as the nuclear extract and frozen at
70°C. Protein concentrations in nuclear and cytoplasmic extracts
were determined by using the Bradford assay (9).
Oligonucleotide labeling.
Oligonucleotides were labeled with
a double-stranded consensus sequence NF-
B and
[
-32P]ATP. The reaction was catalyzed with
T4 polynucleotide kinase and incubated in 10× kinase buffer at 37°C
for 45 min. The reaction was terminated by being heated at 65°C for
10 min. Labeled oligonucleotide was column purified on Sephadex G-25
columns (Amersham Pharmacia Biotech). The radioactivity of the labeled
probe was assayed with a Beckman LS6500 multipurpose scintillation
counter and measured as cpm per microliter of probe.
EMSA.
Five micrograms of nuclear protein was incubated with
binding buffer on ice for 30 min (specific antibodies for p50 and RelA were added for supershift studies). Labeled oligonucleotide
(approximately 100,000 cpm) was then added, and samples were incubated
at room temperature for 1 h. Specificity of binding was
ascertained by cold competition with an excess of unlabeled NF-
B
oligonucleotides, and nonspecific competition was assessed by
incubation with an excess of a double-stranded unlabeled Oct-1 probe.
Protein-DNA complexes were separated from free DNA probe by
electrophoresis with a 6% polyacrylamide gel. Gels were dried under
vacuum on Whatman paper in a Bio-Rad gel dryer and exposed to
autoradiographic film for 12 to 36 h at
70°C with intensifying screens.
Western blot analysis.
Nuclear and cytoplasmic proteins from
tissue extracts were quantitated by the Bradford assay, and 25 to 50 µg of protein was mixed with an equal volume of 2× sample buffer
(containing 0.1% sodium dodecyl sulfate [SDS] and 2-mercaptoethanol)
and boiled for 5 min. Denatured proteins were separated by
electrophoresis on an SDS-polyacrylamide gel along with molecular
weight markers and standards. Proteins were transferred to an
Immobilon-P (Millipore, Bedford Mass.) membrane in a mixture of 25 mM
Tris base, 192 mM glycine, and 5% (vol/vol) methanol (pH 8.2) at 100 V
for 1 h. Nonspecific binding was blocked by soaking the membrane
in phosphate-buffered saline (PBS)-5% nonfat dried milk-0.05% Tween
20 overnight at 4°C. Immunoreactive proteins were detected by
incubating the filter with specific antibodies to RelA (Santa Cruz
Biotechnology, Inc.) for 1 h at room temperature with constant
agitation. Nonspecific binding was washed away by rinsing the filter in
PBS containing 0.05% Tween 20. The filters were incubated with
horseradish peroxidase-conjugated goat anti-rabbit immunoglobulin G
(Santa Cruz Biotechnology) diluted 1:5,000 in Blotto (Tween-PBS-5%
nonfat dried milk) for an hour at room temperature with constant
agitation. The filter was washed three times for 10 min with Tween-PBS.
To develop the image, filters were treated with Renaissance Western
blot luminescent reagent (NEN DuPont) for 5 min and exposed to Biomax
film for 3 to 10 min.
ELISA for cytokine production.
Cytokine assays were
performed with cytoplasmic extracts derived from whole-lung
homogenates. MIP-2 was assayed according to the manufacturer's
instructions with a commercially available ELISA (R&D Systems).
Statistical analysis.
Statistical analyses were performed
with GraphPad InStat version 3.01 for Windows NT (GraphPad Software,
San Diego Calif.) by using the unpaired t test and unpaired
analysis of variance test.
 |
RESULTS |
NF-
B activation in nuclear extracts of lung and liver tissue
following i.p. injection of LPS.
Mice were treated with 5 or 20 µg of i.p. LPS per g and sacrificed 90 min later. Subsequently,
nuclear proteins were extracted from lung and liver tissue. Previous
studies with mice have shown that NF-
B binding in lung and liver is
near maximum at 90 min after i.p. LPS (5). As shown in
Fig. 1, NF-
B binding activity in
nuclear protein extracts from lung tissue of WT and
p47phox
/
mice was minimal in the absence of
LPS treatment. There was induction of NF-
B activation in lung
nuclear protein extracts from WT and p47phox
/
mice 90 min after treatment with i.p. LPS at a dose of 20 µg/g (bands
A and B). Band A was prominently induced only in WT mice. This band was
found by antibody supershifts to contain RelA/p50 heterodimers (data
not shown). Band B represents p50 homodimers, since this complex
supershifted with p50 antibodies but not with RelA antibodies (not
shown). This distinction is important, since RelA, but not p50,
contains a C-terminal transactivation domain (4).

View larger version (54K):
[in this window]
[in a new window]
|
FIG. 1.
EMSA showing NF- B activation in four
p47phox / (knockout [KO]) and four WT mice 90 min
after high-dose i.p. LPS (20 µg/g). Nuclear extracts from two
untreated WT and two untreated p47phox / mice
demonstrated minimal NF- B binding. Lung NF- B binding was
increased in both WT and p47phox / mice, but band A,
which represents RelA/p50 heterodimers, was increased primarily in WT
mice.
|
|
Figure
2 shows NF-

B binding in lung
nuclear protein extracts 90 min after low-dose i.p. LPS (5 µg/g) and
high-dose i.p. LPS
(20 µg/g). After low-dose i.p. LPS, NF-

B
binding was predominantly
composed of p50 homodimers (band B) and was
similar in intensity
in p47
phox
/
and WT mice.
Following high-dose i.p. LPS, lungs from WT mice
demonstrated increased
RelA/p50 heterodimer binding (band A) compared
to
p47
phox
/
mice treated with high-dose i.p. LPS
or either group of mice
treated with low-dose i.p. LPS. Increasing the
dose of i.p. LPS
from 5 to 20 µg/g resulted in increased NF-

B
activation in WT
mice; however, no increase in NF-

B activation was
found in p47
phox
/
mice. These findings
indicate that p47
phox
/
mice were unable to
maximally activate NF-

B after treatment
with high-dose i.p. LPS. In
liver tissue, NF-

B DNA binding activity
was induced in WT and
p47
phox
/
mice by treatment with i.p. LPS (low
and high doses). There were
no detectable differences in NF-

B
binding activity in liver nuclear
extracts from
p47
phox
/
and WT mice after either dose of LPS
(data not shown).

View larger version (61K):
[in this window]
[in a new window]
|
FIG. 2.
EMSA of nuclear protein extracts from lungs obtained 90 min after treatment with 5 and 20 µg of i.p. LPS per g showing
NF- B activation in p47phox / (knockout [KO])
compared to WT animals. After 5 µg of i.p. LPS per g, NF- B binding
is similar in WT and p47phox / mice (predominantly band
B). At 20 µg of i.p. LPS per g, band A is induced in WT mice, but
NF- B binding in p47phox / mice shows a similar
pattern to that seen after low-dose LPS. Specificity of protein binding
for NF- B is shown by cold (c) and nonspecific (ns) competition.
|
|
To confirm differences in RelA nuclear translocation, Western blots for
RelA were performed with nuclear protein extracts
obtained from whole
lung tissue following i.p. LPS and probed
for RelA. Figure
3 demonstrates that
p47
phox
/
mice had reduced amounts of nuclear
RelA in response to high-dose
i.p. LPS (20 µg/g) compared to WT mice.
Nuclear RelA was undetectable
in untreated
p47
phox
/
and WT mice (not shown). These
results confirm the EMSA findings
that
p47
phox
/
mice have deficient NF-

B
activation in lungs after treatment
with high-dose i.p. LPS.

View larger version (33K):
[in this window]
[in a new window]
|
FIG. 3.
Western blot for RelA in nuclear extracts obtained from
lung tissues harvested 90 min following treatment with 20 µg of i.p.
LPS per g. Results for p47phox / (knockout [KO]) mice
are shown in lanes 1 to 5, and those for WT mice are shown in lanes 6 to 9. p47phox / animals had reduced levels of nuclear
RelA compared to WT mice.
|
|
Nuclear NF-
B activity and RelA translocation after treatment
with aerosolized LPS.
LPS (0.1 mg/ml [wt/vol]) was delivered to
mice placed within a sealed container via nebulization at a flow rate
of 8 liters/min over 30 min. Mice were sacrificed 4 h after
treatment, and lung tissue was preserved for determination of NF-
B
binding activity in nuclear extracts and nuclear RelA translocation. We
used a 4-h time point for these studies because previous studies showed that both NF-
B activation and neutrophilic influx are present in the
lungs 4 h after LPS is inhaled (26). In the present
studies, there was marked variability in intensity of the RelA/p50 band in p47phox
/
mice treated with inhaled LPS,
with some animals approximating WT levels of NF-
B activation and
others having decreased levels (Fig. 4A).
This degree of variability was not evident in the control animals.
Overall, DNA binding of the RelA/p50 heterodimer band was reduced in
most p47phox
/
animals compared to WT
controls, but this did not reach statistical significance when assessed
by densitometry (Fig. 5). As assessed by
Western blotting, WT animals had greater amounts of nuclear RelA than
p47phox
/
animals following treatment with
inhaled LPS (Fig. 4B).

View larger version (54K):
[in this window]
[in a new window]
|
FIG. 4.
NF- B activation and nuclear RelA in
p47phox / (knockout [KO]) and WT mice 4 h
following treatment with aerosolized LPS. Results for
p47phox / animals are shown in lanes 1 to 4, and those
for WT animals are shown in lanes 5 to 8. (A) EMSA showing that
p47phox / mice have a more variable response to inhaled
LPS than WT mice. (B) Western blot showing nuclear RelA is reduced in
p47phox / mice compared to WT mice.
|
|

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 5.
Densitometry of the RelA-containing band by EMSA and
nuclear RelA detection by Western blots obtained from
p47phox / and WT mice following i.p. (IP) and
inhaled-LPS treatment. Densitometry values are depicted as a percentage
of the mean density of bands from WT mice in the same experiments (and
on the same blots). Error bars represent the standard error of the
mean. Following i.p. LPS, RelA nuclear translocation and DNA binding
were significantly reduced in knockout mice (P < 0.001). After aerosolized LPS, RelA/p50 DNA binding was not
statistically decreased in p47phox / mice, but nuclear
RelA was reduced in p47phox / mice
(P < 0.05). n = 16 for
p47phox / mice, and n = 15 for WT
mice with i.p. LPS. n = 5 in each group for inhaled
LPS.
|
|
Differences between WT and p47
phox
/
mice in
LPS-induced NF-

B binding in the lungs (RelA/p50 heterodimers) and
nuclear RelA in
the lungs was assessed by densitometry of bands on EMSA
and Western
blots (Fig.
5). The density of the RelA/p50 heterodimer
band (band
A) is reported from four separate experiments in which 16 p47
phox
/
and 15 WT mice were treated with
high-dose (20 µg/g) LPS. After
high-dose i.p. LPS, the RelA/p50
heterodimer binding activity
and RelA concentration in nuclear extracts
from p47
phox
/
mice were decreased compared to
those in WT mice (
P < 0.001).
Following inhaled-LPS
treatment, RelA/p50 heterodimer binding
was not statistically different
between WT and p47
phox
/
mice; however, RelA
translocation was found to be decreased in
p47
phox
/
mice compared with control mice
(
P < 0.05).
CXC chemokine production and recruitment of neutrophils into the
airspace following treatment with LPS.
To evaluate the effects of
altered NF-
B activation in p47phox
/
mice,
levels of the NF-
B-dependent chemokine MIP-2 were measured in lung
tissue homogenates. Baseline MIP-2 levels in the lungs were barely
detectable in WT mice, but were higher in
p47phox
/
mice (Table
1). Following high-dose i.p. LPS (20 µg/g), the MIP-2 concentration was higher in
p47phox
/
mice than in WT mice, but this
difference did not reach statistical significance (Table 1). Four hours
after LPS was inhaled, MIP-2 concentrations in lung tissue homogenates
were increased in p47phox
/
mice compared with
those in WT mice (Table 1). In these studies, alterations in
LPS-induced NF-
B binding and RelA nuclear concentration in
p47phox
/
mice did not correlate with levels
of MIP-2 in lung tissue, indicating that MIP-2 regulation may occur
through a non-NF-
B-dependent mechanism in these mice.
We also examined the effect of LPS treatment on the evolution of
neutrophilic lung inflammation by measuring total and differential
cell
counts in lung lavage fluid obtained from mice following
aerosolized
and i.p. LPS treatments. Baseline lavages obtained
from untreated
p47
phox
/
animals showed neutrophil levels in
excess of that seen in WT
animals (
n = 7 or 8;
P < 0.001) (Fig.
6).
Untreated WT mice have
few neutrophils in lung lavage (1% ± .4% of
total cells), but
p47
phox
/
mice have a
substantial neutrophilia (37% ± 8% of total lavage
cells). Four
hours after aerosol administration of LPS, both WT
and
p47
phox
/
mice had increases in the number of
neutrophils in lung lavage;
however, the percentage of neutrophils in
lung lavage was significantly
higher in
47
phox
/
mice than in WT mice
(
P < 0.05) (Fig.
6). The increased neutrophilic
lung
inflammation in p47
phox
/
mice correlated with
increased MIP-2 concentration in lung homogenates
in these animals, but
contrasted with NF-

B activation and RelA
nuclear translocation. At
24 h after treatment with 20 µg of i.p.
LPS per g, no
significant increase in lung lavage neutrophil counts
from baseline was
found in WT or p47
phox
/
mice, but neutrophil
counts were significantly higher in p47
phox
/
mice than in WT mice (not shown). Therefore, in NADPH oxidase-deficient
mice, LPS-induced NF-

B activation is not a good indicator of
the
inflammatory response. Impaired NF-

B activation in these
mice does
not translate to decreased chemokine expression or diminished
neutrophilic alveolitis.

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 6.
Neutrophilic lung inflammation depicted as percentage of
total cells in lung lavage (A) or as the total number of lavage cells
(B). Lung lavage was performed with untreated WT and
p47phox / (knockout [KO]) mice (black bars) and in
both groups 4 h after treatment with aerosolized LPS (gray bars).
Results are presented as means ± standard errors.
n = 5 in each treatment group.
n = 7 for untreated controls.
|
|
 |
DISCUSSION |
Multiple in vivo and in vitro studies examining the effects of
oxidant exposure (7, 27) or addition of antioxidants such as N-acetylcysteine (4) and
pyrolidinedithiocarbamate (20) suggest that the
intracellular redox state may modulate NF-
B activity, although the
exact mechanism is presently unknown. We found a dose-dependent effect
of LPS on NF-
B activation in p47phox
/
and
WT mice. Low-dose i.p. LPS induced similar NF-
B activation in
p47phox
/
and WT mice. In contrast, with
high-dose i.p. LPS, a disparity became evident with attenuated binding
of RelA/p50 heterodimers in p47phox
/
mice.
This suggests that either ROS are not required in the NF-
B activation pathway following low-dose LPS, or
p47phox
/
mice are able to compensate for a
defect in the NADPH oxidase system by engaging alternate mechanisms of
ROS production in response to low-dose LPS; however, our finding of
altered NF-
B activation and decreased nuclear RelA translocation in
p47phox
/
mice following high-dose i.p. LPS
indicates that maximal activation of the NF-
B signal transduction
pathway in the lungs by i.p. LPS is dependent on ROS formation through
the NADPH oxidase pathway. Our findings are consistent with a previous
report of blunted NF-
B activation in liver tissue in
p47phox
/
mice exposed to ethanol in a model
of alcoholic liver disease (25). In that model, free
radical production was shown to be deficient in
p47phox
/
mice compared to that in WT controls
(19).
The NADPH oxidase pathway is the major means of superoxide generation
in neutrophilic leukocytes and macrophages (1). Mice that
lack p47phox have reduced capacity to generate
superoxide via the NADPH oxidase pathway, but retain the mechanism to
do so via alternate pathways (18). The exact contribution
of phagocytic NADPH oxidase to lung ROS production is not clearly
defined. While originally described in neutrophils and macrophages
(1), NADPH oxidase has subsequently been defined in a
variety of nonphagocytes, including smooth muscle cells, synoviocytes
and chondrocytes (1), endothelial cells (16),
and epithelial cells (15, 31). However, the relative concentrations and activities of NADPH oxidase in each of these cell
types have not been examined.
NF-
B increases recruitment of inflammatory effector cells by
up-regulating gene expression of CXC chemokines (23). Our finding that NF-
B DNA binding did not correlate with inflammatory end points such as neutrophil lung infiltration and chemokine production is interesting and suggests that other regulatory factors may be more important than NF-
B in regulating neutrophilic
alveolitis in these experimental settings. These data suggest that DNA
binding activity as detected on EMSA is not a good predictor of the
severity of inflammation in all situations.
Lack of NADPH oxidase results in airspace neutrophilia in untreated
mice as well as in an exaggerated neutrophilic influx following an
inflammatory stimulus. Other studies have shown that mice lacking the
gp91 subunit have increased neutrophilic infiltration following
exposure to Aspergillus fumigatus (21) and
Listeria (14). Similarly,
p47phox
/
mice exposed to thioglycolate or
Mycobacterum tuberculosis exhibited a profound neutrophilia,
exceeding that found in WT controls (11, 24). Neutrophils
obtained from gp91
/
and
p47phox
/
mice have been shown to have
diminished pathogen killing compared to WT phagocytes (21,
24). In infection models, it is possible that failure to clear
pathogens results in persistence of the inflammatory signals, causing
exuberant neutrophilia in NADPH oxidase-deficient animals. It is also
possible that these NADPH oxidase knockout mice have exaggerated
neutrophil influx in response to a given inflammatory stimulus.
Treatment of NADPH oxidase knockout mice with both viable and
heat-inactivated Aspergillus fumigatus results in heightened
pulmonary neutrophil recruitment compared with that in controls
(21). This finding, along with ours, suggests that
impaired pathogen clearance is not the sole stimulus for increased
neutrophil recruitment in these mice.
In summary, we have shown that the NADPH oxidase pathway in mice is
important for maximal activation of NF-
B following treatment with
LPS. This defect in NF-
B activation does not translate to diminished
production of MIP-2 or decreased neutrophil recruitment to the lungs of
p47phox
/
mice. Apparently, neutrophils are
recruited by a non-NF-
B-dependent mechanism in these mice.
 |
ACKNOWLEDGMENTS |
This work was supported by the U.S. Department of Veterans
Affairs and grant no. HL 61419 from the National Heart Lung and Blood
Institute, National Institutes of Health, Bethesda, Md.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Division of
Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University
School of Medicine, T-1217 MCN, Nashville, TN 27232-2650. Phone: (615) 327-4751, ext 7928. Fax: (615) 340-2347. E-mail:
john.christman{at}mcmail.vanderbilt.edu.
Editor:
R. N. Moore
 |
REFERENCES |
| 1.
|
Babior, B.
1999.
NADPH oxidase: an update.
Blood
93:1464-1476[Free Full Text].
|
| 2.
|
Baeuerle, P., and T. Henkel.
1994.
Function and activation of NF-kB in the immune system.
Annu. Rev. Immunol.
12:141-179[Medline].
|
| 3.
|
Blackwell, T., and J. Christman.
1997.
The role of nuclear factor-kB in cytokine gene regulation.
Am. J. Respir. Cell Mol. Biol.
17:3-9[Abstract/Free Full Text].
|
| 4.
|
Blackwell, T. S.,
T. R. Blackwell,
E. P. Holden,
B. W. Christman, and J. W. Christman.
1996.
In vivo antioxidant treatment suppresses nuclear factor-kB activation and neutrophilic lung inflammation.
J. Immunol.
157:1630-1637[Abstract].
|
| 5.
|
Blackwell, T. S.,
F. E. Yull,
C.-L. Chen,
A. Venkatakrishnan,
T. R. Blackwell,
D. J. Hicks,
L. H. Lancaster,
J. W. Christman, and L. D. Kerr.
2000.
Multi-organ NF-kB activation in a transgenic mouse model of systemic inflammation.
Am. J. Respir. Crit. Care Med.
162:1095-1101[Abstract/Free Full Text].
|
| 6.
|
Bohler, T,
J. Waiser,
H. Hepburn,
J. Gaedeke,
C. Lehmann,
P. Hanibach,
K. Budde, and H. H. Neumayer.
2000.
TNF- and IL-1 induce apoptosis in subconfluent rat mesangial cells. Evidence for the involvement of hydrogen peroxide and lipid peroxidation as second messengers.
Cytokine
12:986-991[CrossRef][Medline].
|
| 7.
|
Bonizzi, G.,
J. Piette,
M. P. Merville, and V. Bours.
2000.
Cell type-specific role for reactive oxygen species in nuclear factor-kappaB activation by interleukin-1.
Biochem. Pharmacol.
59:7-11[CrossRef][Medline].
|
| 8.
|
Bowie, A., and L. O'Neil.
2000.
Oxidative stress and nuclear factor B activation. A re-assessment of the evidence in the light of recent discoveries.
Biochem. Pharmacol.
59:13-23[CrossRef][Medline].
|
| 9.
|
Bradford, M. M.
1976.
A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding.
Anal. Biochem.
72:248-254[CrossRef][Medline].
|
| 10.
|
Christman, J.,
L. Lancaster, and T. Blackwell.
1998.
Nuclear factor-kB: a pivotal role in the systemic inflammatory response syndrome and new target for therapy.
Intensive Care Med.
24:1131-1138[CrossRef][Medline].
|
| 11.
|
Cooper, A. M.,
B. H. Segal,
A. A. Frank,
S. M. Holland, and I. M. Orme.
2000.
Transient loss of resistance to pulmonary tuberculosis in p47phox / mice.
Infect. Immun.
68:1231-1234[Abstract/Free Full Text].
|
| 12.
|
Dalton, T.,
H. Shertzer, and A. Puga.
1999.
Regulation of gene expression by reactive oxygen.
Annu. Rev. Pharmacol. Toxicol.
39:67-101[CrossRef][Medline].
|
| 13.
|
Deryckere, F., and F. Gannon.
1994.
A one-hour minipreparation technique for extraction of DNA binding proteins from animal tissues.
BioTechniques
16:405[Medline].
|
| 14.
|
Dinauer, M.,
M. Deck, and E. Unanue.
1997.
Mice lacking reduced nicotinamide adenine dinucleotide phosphate oxidase activity show increased susceptibility to early infection with Listeria monocytogenes.
J. Immunol.
158:5581-5583[Abstract].
|
| 15.
|
Geiszt, M.,
J. B. Kopp,
P. Varnal, and T. Leto.
2000.
Identification of Renox, an NAD(P)H oxidase in kidney.
Proc. Natl. Acad. Sci. USA
97:8010-8014[Abstract/Free Full Text].
|
| 16.
|
Gorlach, A.,
R. P. Brandes,
K. Nguyen,
M. Amidi,
F. Dehgani, and R. Busse.
2000.
A gp91 phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall.
Circ. Res.
87:26-32[Abstract/Free Full Text].
|
| 17.
|
Hutter, D., and J. Greene.
2000.
Influence of the cellular redox state on NF-kB regulated gene expression.
J. Cell. Physiol.
183:45-52[CrossRef][Medline].
|
| 18.
|
Jackson, S.,
J. Gallin, and S. Holland.
1995.
The p47phox mouse knock-out model of chronic granulomatous disease.
J. Exp. Med.
182:751-758[Abstract/Free Full Text].
|
| 19.
|
Kono, H.,
I. Rusyn,
B. U. Bradford,
M. Yin,
A. Dikalova,
M. B. Kadiiska,
H. D. Connor,
R. P. Mason,
B. H. Segal,
S. M. Holland, and R. G. Thurman.
2000.
Identification of the source of oxidants in alcoholic liver disease: studies in knockout mice.
J. Clin. Investig.
106:867-872[Medline].
|
| 20.
|
Meyer, M.,
R. Schreck, and P. Baeuerle.
1993.
H2O2 and antioxidants have opposite effects on activation of NF- B and AP-1 in intact cells: AP-1 as secondary antioxidant responsive factor.
EMBO J.
12:2005-2015[Medline].
|
| 21.
|
Morgenstern, D. E.,
M. A. Gifford,
L. L. Li,
C. M. Doerschuk, and M. C. Dinauer.
1997.
Absence of respiratory burst in X-linked chronic granulomatous disease mice leads to abnormalities in both host defense and inflammatory response to Aspergillus fumigatus.
J. Exp. Med.
185:207-218[Abstract/Free Full Text].
|
| 22.
|
Nakamura, H.,
K. Nakamura, and J. Yodoi.
1997.
Redox regulation of cellular activation.
Annu. Rev. Immunol.
15:351-369[CrossRef][Medline].
|
| 23.
|
Pahl, H.
1999.
Activators and target genes of Rel/NF-kB transcription factors.
Oncogene
18:6853-6866[CrossRef][Medline].
|
| 24.
|
Pollock, J. D.,
D. A. Williams,
M. A. Gifford,
L. L. Li,
X. Du,
J. Fisherman,
S. H. Orkin,
C. M. Doerschuk, and M. C. Dinauer.
1995.
Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production.
Nat. Genet.
9:202-209[CrossRef][Medline].
|
| 25.
|
Rusyn, I.,
S. Yamashina,
B. H. Segal,
R. Schoonhoven,
S. M. Holland,
R. C. Cattley,
J. A. Swenberg, and R. G. Thurman.
2000.
Oxidants from NADPH oxidase are involved in triggering cell proliferation in the liver due to peroxisome proliferators.
Cancer Res.
60:4798-4803[Abstract/Free Full Text].
|
| 26.
| Sadikot, R. T., E. D. Jansen, T. R. Blackwell, O. Zoia, F. E. Yull, J. W. Christman, and T. S. Blackwell. High dose dexamethasone accentuates NF-kB activation
in endotoxin-treated mice. Am. J. Respir. Crit. Care Med., in
press.
|
| 27.
|
Schreck, R.,
P. Rieber, and P. Baeuerle.
1997.
Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kB transcription factor and HIV-1.
EMBO J.
10:2247-2258[Medline].
|
| 28.
|
Segal, B. H.,
T. L. Leto,
J. I. Gallin,
H. L. Malech, and S. M. Holland.
2000.
Genetics, biochemistry, and clinical features of chronic granulomatous disease.
Medicine (Baltimore)
79:170-200[CrossRef][Medline].
|
| 29.
|
Suzuki, Y.,
H. Forman, and A. Sevanian.
1997.
Oxidants as stimulators of signal transduction.
Free Radic. Biol. Med.
22:269-285[CrossRef][Medline].
|
| 30.
|
Tolando, R.,
A. Jovanovic,
R. Brigelius-Flohe,
F. Ursini, and M. Maiorino.
2000.
Reactive oxygen species and pro-inflammatory cytokine signaling in endothelial cells: effects of selenium supplementation.
Free Radic. Biol. Med.
28:979-986[CrossRef][Medline].
|
| 31.
|
Wang, D.,
C. Youngson,
V. Wong,
H. Yeger,
M. C. Dinauer,
E. Vega-Saenz de Miera,
B. Rudy, and C. Cutz.
1996.
NADPH oxidase and hydrogen peroxide sensitive K+ channel may function as an oxygen sensor complex in airway chemoreceptors and small cell lung carcinoma cell lines.
Proc. Natl. Acad. Sci. USA
93:13182-13187[Abstract/Free Full Text].
|
Infection and Immunity, October 2001, p. 5991-5996, Vol. 69, No. 10
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.10.5991-5996.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Yao, H., Edirisinghe, I., Yang, S.-R., Rajendrasozhan, S., Kode, A., Caito, S., Adenuga, D., Rahman, I.
(2008). Genetic Ablation of NADPH Oxidase Enhances Susceptibility to Cigarette Smoke-Induced Lung Inflammation and Emphysema in Mice. Am. J. Pathol.
172: 1222-1237
[Abstract]
[Full Text]
-
Li, L., Frei, B.
(2006). Iron Chelation Inhibits NF-{kappa}B-Mediated Adhesion Molecule Expression by Inhibiting p22phox Protein Expression and NADPH Oxidase Activity. Arterioscler. Thromb. Vasc. Bio.
26: 2638-2643
[Abstract]
[Full Text]
-
Lee, Y.C. G., Knight, D. A., Lane, K. B., Cheng, D. S., Koay, M. A., Teixeira, L. R., Nesbitt, J. C., Chambers, R. C., Thompson, P. J., Light, R. W.
(2005). Activation of proteinase-activated receptor-2 in mesothelial cells induces pleural inflammation. Am. J. Physiol. Lung Cell. Mol. Physiol.
288: L734-L740
[Abstract]
[Full Text]
-
Balish, E., Warner, T. F., Nicholas, P. J., Paulling, E. E., Westwater, C., Schofield, D. A.
(2005). Susceptibility of Germfree Phagocyte Oxidase- and Nitric Oxide Synthase 2-Deficient Mice, Defective in the Production of Reactive Metabolites of Both Oxygen and Nitrogen, to Mucosal and Systemic Candidiasis of Endogenous Origin. Infect. Immun.
73: 1313-1320
[Abstract]
[Full Text]
-
Chatterjee, S., Fisher, A. B.
(2004). ROS to the rescue. Am. J. Physiol. Lung Cell. Mol. Physiol.
287: L704-L705
[Full Text]
-
Mizgerd, J. P., Lupa, M. M., Hjoberg, J., Vallone, J. C., Warren, H. B., Butler, J. P., Silverman, E. S.
(2004). Roles for early response cytokines during Escherichia coli pneumonia revealed by mice with combined deficiencies of all signaling receptors for TNF and IL-1. Am. J. Physiol. Lung Cell. Mol. Physiol.
286: L1302-L1310
[Abstract]
[Full Text]
-
Sadikot, R. T., Zeng, H., Yull, F. E., Li, B., Cheng, D.-s., Kernodle, D. S., Jansen, E. D., Contag, C. H., Segal, B. H., Holland, S. M., Blackwell, T. S., Christman, J. W.
(2004). p47phox Deficiency Impairs NF-{kappa}B Activation and Host Defense in Pseudomonas Pneumonia. J. Immunol.
172: 1801-1808
[Abstract]
[Full Text]
-
Brown, J. R., Goldblatt, D., Buddle, J., Morton, L., Thrasher, A. J.
(2003). Diminished production of anti-inflammatory mediators during neutrophil apoptosis and macrophage phagocytosis in chronic granulomatous disease (CGD). J. Leukoc. Biol.
73: 591-599
[Abstract]
[Full Text]
-
Forman, H. J., Torres, M.
(2002). Reactive Oxygen Species and Cell Signaling: Respiratory Burst in Macrophage Signaling. Am. J. Respir. Crit. Care Med.
166: S4-8
[Abstract]
[Full Text]
-
Hsu, H.-Y., Wen, M.-H.
(2002). Lipopolysaccharide-mediated Reactive Oxygen Species and Signal Transduction in the Regulation of Interleukin-1 Gene Expression. J. Biol. Chem.
277: 22131-22139
[Abstract]
[Full Text]
-
Yang, S., Panoskaltsis-Mortari, A., Shukla, M., Blazar, B. R., Haddad, I. Y.
(2002). Exuberant Inflammation in Nicotinamide Adenine Dinucleotide Phosphate-Oxidase-Deficient Mice After Allogeneic Marrow Transplantation. J. Immunol.
168: 5840-5847
[Abstract]
[Full Text]
-
Gao, X.-p., Standiford, T. J., Rahman, A., Newstead, M., Holland, S. M., Dinauer, M. C., Liu, Q.-h., Malik, A. B.
(2002). Role of NADPH Oxidase in the Mechanism of Lung Neutrophil Sequestration and Microvessel Injury Induced by Gram-Negative Sepsis: Studies in p47phox-/- and gp91phox-/- Mice. J. Immunol.
168: 3974-3982
[Abstract]
[Full Text]